Phase II study of semorinemab in early Alzheimer's misses key efficacy endpoints Sep. 25, 2020 No Comments
IRDye800CW-nimotuzumab enters phase I/II study for image-guided lung cancer surgery Sep. 16, 2020 No Comments
Ultra-sensitive antigen testing could help identify patients at risk for severe COVID-19 Sep. 10, 2020 No Comments
FluoGuide obtains Danish clearance for phase I/II trial of FG-001 to guide glioma surgery Sep. 7, 2020 No Comments
First-in-human study of [124I]JS-001 PET/CT and PET/MR in patients with melanoma Aug. 5, 2020 No Comments
RSS